Raf Remijsen
Head of Treasury & Risk Management at UCB | Antwerp Metropolitan Area, Belgium
Raf Remijsen’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
ContactOut Insights • AI Generated
Raf Remijsen serves as the Head of Treasury & Risk Management at UCB, a pharmaceutical company dedicated to developing treatments for severe central nervous system and immunological conditions. Based in the Antwerp metropolitan area, he directs financial oversight and risk management initiatives to support the organization’s operational stability and strategic objectives. His professional background includes academic training from the University of Antwerp, positioning him to manage complex treasury functions within a highly regulated global healthcare environment.
BEST APPROACH TO REACH Raf Remijsen
Given the strong confidence in professional profile data alongside absent direct contact metrics, initiate outreach through LinkedIn by sharing a concise note about evolving treasury practices in the Belgian pharmaceutical market to secure a follow-up conversation.
Head of Treasury & Risk Management at UCB in March 2016 - Present
Senior Director Group Treasury & Corporate Finance at UCB in February 2014 - February 2016
Director Treasury & Corporate Finance at UCB in March 2011 - January 2014
Associate Director International Treasury at UCB in September 2008 - February 2011
Finance Manager - Treasury at The Dow Chemical Company in October 2000 - August 2008
Credit Analyst at Bank J. Van Breda & C° in August 1997 - September 2000
University of Antwerp, Master Applied Economics, July 1993 to July 1997
At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine. We are driven by the experiences of patients and caregivers, and inspired to pursue innovations that create real value - not just in clinical outcomes, but in everyday moments, dreams pursued, and simple pleasures enjoyed. Our ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives. From our headquarters in Belgium to nearly 40 countries around the world, we nurture a culture of respect and care. By listening deeply and collaborating across borders and disciplines, we enable cutting-edge research shaped by patients’ needs. Through strong connections with healthcare professionals, partners, and communities, we strive to make a lasting impact - today and into the future. We're inspired by patients, driven by science.
Discover more about UCB
Head of Business Excellence, Patient Supply at UCB
Sr Director, Head of Business Excellence at UCB
(September 2024 – Present)
Senior Project Leader
Senior Project Leader at UCB
(June 2025 – Present)
Head of Clinical Supply Chain
Head of Clinical Supply Chain at UCB
(September 2024 – Present)
Global TA&L Launch Excellence Lead
Global TA&L Launch Excellence Lead at UCB
(June 2022 – Present)
Head of Safety Histology | PhD
Senior Scientist at UCB
(October 2020 – Present)
Gene Therapy Process Engineering Lead
Gene Therapy Process Engineering Lead at UCB
(September 2024 – Present)
What is Raf Remijsen email address?
Email Raf Remijsen at [email protected]. This email is the most updated Raf Remijsen's email found in 2026.
How to contact Raf Remijsen?
To contact Raf Remijsen send an email to [email protected]. (updated on November 07, 2025)
What company does Raf Remijsen work for?
Raf Remijsen works for UCB.
What is Raf Remijsen's role at UCB?
Raf Remijsen is Head of Treasury & Risk Management
What industry does Raf Remijsen work in?
Raf Remijsen works in the Pharmaceuticals industry.
